UNSPSC 51102831: Chloramphenicol/hydrocortisone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102831 Chloramphenicol/hydrocortisone is a Commodity code that nominally describes a specific antibiotic-corticosteroid combination product, yet recent state and local solicitations tagged under this code span a much broader range of pharmaceutical and medical supply procurement — including naloxone and drug deactivation systems, generic pharmaceuticals distributed through multistate cooperative agreements, direct-to-manufacturer prescription programs, and emergency medical and first aid supplies for fire departments. State and local governments soliciting under this code include county health departments, state health and human services commissions, municipalities, and cooperative purchasing alliances serving multiple jurisdictions. The scope of work reflects a fragmented mix driven by the specificity of the nominal UNSPSC classification: individual health jurisdictions procure targeted pharmaceutical products and medical consumables for clinical, emergency response, and community health programs, while larger state-level and multistate cooperative vehicles procure volumes of generic pharmaceuticals and OTC products intended for distribution across multiple facilities and agencies. Issuing bodies range from single municipalities managing emergency medical supply chains to multistate collaborative purchasing organizations coordinating across state lines.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and a July 26, 2023 response deadline. The City of Tampa released IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount, and a March 13, 2026 deadline. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program with an April 3, 2026 response deadline. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The mismatch between the code's nominal scope and the diversity of recent solicitations suggests limited direct relevance — vendors targeting this code should verify alignment with actual commodity needs before investing in pursuit.